Kenota Health

About:

Kenota Health develops next-generation diagnostic tools intended to be used for allergy testing in humans.

Top Investors: Y Combinator, Tencent, Accelerator Centre, Draper Associates, 1517 Fund

Description:

Kenota Health develops next-generation rapid point-of-care system intended to be used for allergy testing in humans. Kenota's diagnostic tools are safe, simple, and offer a cheaper alternative to allergy testing using a thorough non-invasive technology, enabling physicians to improve patient outcomes.

Total Funding Amount:

$9.05M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Kitchener, Ontario, Canada

Founded Date:

2014-01-01

Founders:

Eric Blondeel, Moufeed Kaddoura

Number of Employees:

11-50

Last Funding Date:

2020-12-07

IPO Status:

Private

Industries: